Back

Prognostic significance of coexistent coronary artery disease in patients undergoing transcatheter aortic valve implantation for aortic stenosis

1 September 2024 (07:55 - 08:50)
Organised by: Logo
Congress Presentation Part of: TAVI: common and unusual complications and their management Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kush Patel

Barts Health NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Long-term clinical and imaging outcomes of patients undergoing percutaneous femoral intervention following TAVI-related vascular access complications
Doctor M. Lima (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Impact of aortic valve calcium score on conductive disturbances after transcatheter aortic valve implantation: a monocentre retrospective study
Doctor C. Fauvel (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Pacing dependency after TAVI, a lasting hazard in every case?
Doctor R. Barbosa Sousa (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Coronary access after Transcatheter Aortic Valve Replacement (TAVR): a systematic review and meta-analysis of observational studies
Doctor M. Nebiolo (Turin, IT)
Abstract Slides Video
Presentation thumbnail
TAVI-related vascular access complications: are Viabahn stents a good option?
Doctor A. Ferreira (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
TAVI: common and unusual complications and their management

The Event

Event poster

ESC Congress 2024

1 September 2024 07:55 CET
You may be interested in
thumbnail
Congress Session
Improving prognosis after TAVI
thumbnail
Congress Session
Transcatheter aortic valve implantation: outcomes, complications, and adjunctive therapy
thumbnail
Congress Session
Predictors of outcomes in transcatheter aortic valve implantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources